[go: up one dir, main page]

NO811058L - 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidin-4-on-derivater - Google Patents

3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidin-4-on-derivater

Info

Publication number
NO811058L
NO811058L NO811058A NO811058A NO811058L NO 811058 L NO811058 L NO 811058L NO 811058 A NO811058 A NO 811058A NO 811058 A NO811058 A NO 811058A NO 811058 L NO811058 L NO 811058L
Authority
NO
Norway
Prior art keywords
piperidinylalkyl
pyrido
pyrimidine
derivative
Prior art date
Application number
NO811058A
Other languages
English (en)
Other versions
NO156752C (no
NO156752B (no
Inventor
Ludo Edmond Josephine Kennis
Josephus Carolus Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO811058L publication Critical patent/NO811058L/no
Publication of NO156752B publication Critical patent/NO156752B/no
Publication of NO156752C publication Critical patent/NO156752C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO811058A 1980-03-28 1981-03-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater NO156752C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28
US06/191,632 US4342870A (en) 1980-03-28 1980-09-29 Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives

Publications (3)

Publication Number Publication Date
NO811058L true NO811058L (no) 1981-09-29
NO156752B NO156752B (no) 1987-08-10
NO156752C NO156752C (no) 1987-11-18

Family

ID=26832744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO811058A NO156752C (no) 1980-03-28 1981-03-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater

Country Status (22)

Country Link
US (1) US4342870A (no)
EP (1) EP0037265B1 (no)
AU (1) AU537700B2 (no)
BG (1) BG36199A3 (no)
CA (1) CA1163994A (no)
CS (1) CS256366B2 (no)
DE (1) DE3168433D1 (no)
DK (1) DK159390C (no)
ES (1) ES8300763A1 (no)
FI (1) FI71737C (no)
GR (1) GR72488B (no)
HU (1) HU187329B (no)
IE (1) IE51319B1 (no)
IL (1) IL62494A (no)
MA (1) MA19107A1 (no)
NO (1) NO156752C (no)
NZ (1) NZ196522A (no)
PH (1) PH16530A (no)
PT (1) PT72740B (no)
RO (1) RO82508A (no)
SU (1) SU1068037A3 (no)
YU (1) YU43010B (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443451A (en) 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US4548938A (en) * 1981-07-15 1985-10-22 Janssen Pharmaceutica N.V. 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4581171A (en) * 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4888426A (en) * 1983-11-30 1989-12-19 Janssen Pharmaceutica N.V. 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine
US4695569A (en) * 1983-11-30 1987-09-22 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
SG47757A1 (en) * 1986-09-22 1998-04-17 Janssen Pharmaceutica Nv Serotonin antagonists for treating wounds
IL90879A0 (en) * 1988-09-02 1990-02-09 Janssen Pharmaceutica Nv 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
CA2000786C (en) * 1988-11-07 1999-01-26 Cornelus G. M. Janssen 3-piperidinyl-1,2-benzisoxazoles
WO1990006303A1 (en) * 1988-12-02 1990-06-14 Pfizer Inc. Arylpiperidine derivatives
JPH04504263A (ja) * 1989-03-23 1992-07-30 マリンクロッド・インコーポレイテッド 放射性沃素又は臭素標識ピペリジン化合物、並びに上記化合物の及び上記化合物を含む組成物の製法
DE4138756A1 (de) * 1991-11-26 1993-05-27 Troponwerke Gmbh & Co Kg Kombination mit neuroprotektiver wirkung
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
ES2163407T3 (es) * 1992-02-13 2002-02-01 Merrell Pharma Inc Derivados piperidinilos tiaciclicos.
DE69330283T2 (de) * 1992-07-13 2002-01-10 Janssen Pharmaceutica N.V., Beerse Neue 4-(3-benzofuranyl) piperidinyl und 4-(3-benzothienyl) piperidinyl-derivate und diese enthaltende pharmazeutische zusammenstellungen
PL314481A1 (en) 1993-11-19 1996-09-16 Janssen Pharmaceutica Nv Microencapsulated substituted 3-piperidinyl 1,2-benzoisoxazoles and 1,2-benzoisothiazoles
ES2085234B1 (es) * 1994-02-24 1997-01-16 Vita Invest Sa Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
TW421649B (en) * 1995-01-31 2001-02-11 Janssen Pharmaceutica Nv 4-(1H-indol-1yl)-1-piperidinyl derivatives
US5753664A (en) * 1995-03-16 1998-05-19 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
CN100390146C (zh) * 2002-11-13 2008-05-28 斯索恩有限公司 制备利培酮的方法和用于该方法的中间体
WO2004094415A1 (en) * 2003-04-22 2004-11-04 Synthon B.V. Risperidone monohydrochloride
DK3106166T3 (da) 2008-02-29 2021-01-11 Vm Therapeutics Llc Forbindelser til behandling af smertesyndrom og andre lidelser
SG11201404713PA (en) * 2012-02-10 2014-09-26 Ptc Therapeutics Inc Compounds for treating spinal muscular atrophy
MX352962B (es) 2012-03-01 2017-12-15 Ptc Therapeutics Inc Compuestos para tratar atrofia muscular espinal.
KR102109992B1 (ko) 2012-03-23 2020-05-13 피티씨 테라퓨틱스, 인크. 척수성 근위축증을 치료하기 위한 화합물
WO2014143915A1 (en) * 2013-03-15 2014-09-18 Vm Therapeutics Llc Novel crystalline forms
US10195202B2 (en) 2013-12-19 2019-02-05 Ptc Therapeutics, Inc. Methods for modulating the amount of RNA transcripts
WO2016196386A1 (en) 2015-05-30 2016-12-08 Ptc Therapeutics, Inc. Methods for modulating rna splicing
HUE055031T2 (hu) 2015-12-10 2021-10-28 Ptc Therapeutics Inc Módszerek Huntington-kór kezelésére
AU2017363369A1 (en) 2016-11-28 2019-05-30 Ptc Therapeutics, Inc Methods for modulating RNA splicing
JP7376471B2 (ja) 2017-06-05 2023-11-08 ピーティーシー セラピューティクス， インコーポレイテッド ハンチントン病を処置するための化合物
WO2018232039A1 (en) 2017-06-14 2018-12-20 Ptc Therapeutics, Inc. Methods for modifying rna splicing
WO2019005993A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
CN111182898B (zh) 2017-06-28 2024-04-16 Ptc医疗公司 用于治疗亨廷顿氏病的方法
CN112135815A (zh) 2018-03-27 2020-12-25 Ptc医疗公司 用于治疗亨廷顿氏病的化合物
ES2983003T3 (es) 2018-06-27 2024-10-21 Ptc Therapeutics Inc Compuestos heterocíclicos y heteroarílicos para el tratamiento de la enfermedad de Huntington
MX2020014315A (es) 2018-06-27 2021-05-27 Ptc Therapeutics Inc Compuestos de heteroarilo para tratar la enfermedad de huntington.
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412094A (en) * 1967-06-21 1968-11-19 Searle & Co 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
JPS5146497A (en) * 1974-10-19 1976-04-20 Masato Aiura Hobuban
JPS525795A (en) * 1975-06-28 1977-01-17 Sankyo Co Ltd Preparation of tetrahydro pyridopyrimidinone derivatives
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom

Also Published As

Publication number Publication date
NO156752C (no) 1987-11-18
EP0037265B1 (en) 1985-01-23
DK138281A (da) 1981-09-29
ES500814A0 (es) 1982-11-01
IE810706L (en) 1981-09-28
DK159390B (da) 1990-10-08
FI71737C (fi) 1987-02-09
YU43010B (en) 1989-02-28
MA19107A1 (fr) 1981-10-01
ES8300763A1 (es) 1982-11-01
PT72740B (en) 1982-11-16
HU187329B (en) 1985-12-28
BG36199A3 (en) 1984-09-14
RO82508A (ro) 1983-09-26
AU6842981A (en) 1981-10-01
NO156752B (no) 1987-08-10
IE51319B1 (en) 1986-12-10
NZ196522A (en) 1985-10-11
AU537700B2 (en) 1984-07-05
IL62494A0 (en) 1981-05-20
CA1163994A (en) 1984-03-20
RO82508B (ro) 1983-08-30
PH16530A (en) 1983-11-10
DE3168433D1 (de) 1985-03-07
FI810956L (fi) 1981-09-29
CS256366B2 (en) 1988-04-15
GR72488B (no) 1983-11-14
EP0037265A1 (en) 1981-10-07
US4342870A (en) 1982-08-03
DK159390C (da) 1991-03-04
SU1068037A3 (ru) 1984-01-15
FI71737B (fi) 1986-10-31
PT72740A (en) 1981-04-01
YU81081A (en) 1983-12-31
IL62494A (en) 1984-08-31

Similar Documents

Publication Publication Date Title
NO811058L (no) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidin-4-on-derivater
BE867295A (fr) 3-(1h-tetrazol-5-yl)-4h-pyrido (1,2-a) pyrimidine-4-ones
NO810198L (no) Fremgangsmaate ved fremstilling av imidazo (1,2-a)pyridiner.
FI822266A0 (fi) Nya imidazo/1,2-a/pyridiner och pyraziner
DK495287D0 (da) 2-eller 3-arylsubstituerede imidazo(1,2-a)pyridi ner
JPS56150091A (en) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidine- 4-one derivative and its manufacture
ATE33651T1 (de) Imidazo(1,5-a)pyridin-derivate.
AU516695B2 (en) Heterocyclic substituted imidazo (1, 2-a)pyridines
AR229519A1 (es) Procedimiento de preparacion de derivados de 2,3-dihidro-9-fenil-1h-pirazolo(1,2-a)-indazolio
FI864891A7 (fi) Foerfarande foer framstaellning av 6,7,8,9-tetrahydro-10-metylpyrido/1,2-a/indol-9-aminer och deras derivat.
FI801464A7 (fi) Foerfarande foer framstaellning av substituerade pyrido/1,2-a/pyrimidiner
FI834664A7 (fi) Substituoidut imidatso(1,5-a)pyridiinit.
FI864003A7 (fi) Pyrido /1,2-a/ pyrimidinderivat, foerfaranden foer framstaellning daerav och dessa innehaollande farmaceutiska kompositioner foer behandling av allergiska sjukdomar.
DE3682244D1 (de) Substituierte dihydroimidazo(1,2-a)chinoxalinderivate.
FI853027A0 (fi) Imidazo/1,2-a/kinoliner, deras framstaellning och deras terapeutiska tillaempning.
DE3267918D1 (de) Pyrazolo(3,4-b)pyridine derivatives
FI781797A7 (fi) Foerfarande foer framstaellning av imidazo (1,2-a) pyridiner
FI813757L (fi) Nytt foerfarande foer framstaellning av imidazo/4,5-b/pyridiner och -pyrimidiner
DK33684D0 (da) Pyrazino (2',3'-3,4)pyrido(1,2-a)-indol-derivater
GB2080794B (en) 1,6-naphthyridine derivatives
ATE11415T1 (de) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidi - 4-on-derivate.
DE3578177D1 (de) 4,7-dihydropyrazolo(3,4-b)pyridin-derivate.
FI801513A7 (fi) 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido /1,2-a/ pyrimidin-4-on-derivat och foerfarande foer deras framstaellning
FI781796A7 (fi) Foerfarande foer framstaellning av imidazo (1,2-a) pyridiner
FI821308A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-substituerade imidazo/1,2-a/kinoxaliner